Constellation Pharmaceuticals

Translating stellar science into breakthrough medicines

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel tumor-targeted and immuno-oncology therapies based on its pioneering research in cancer epigenetics.

Founded in 2008 by seasoned scientific, medical and business leaders, Constellation was the first biopharmaceutical company to target selective regulators of epigenetic function as a potential therapeutic approach.


Visit Constellation Pharma’s offices in 3D!

Featured in the Boston Herald

Constellation Pharmaceuticals